Newsletter out today:
Both, JC and PH noticed the terrible sp development despite the clinical progress. Hello, it was PH who got CHM down like he did it to IMU and RAD.
One can only hope that one day big pharma will take notice, the ASX clearly hasn't and unlikely will and the chair hasn't even tried to raise at a price reflecting the achievements.
The gap between the clinical progress and the sp is going to become wider than the universe' width. Which way will the BIG BANG go, Boom or Bust?
GLTA
Chimeric: Media Thread, page-626
-
- There are more pages in this discussion • 265 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.002(20.0%) |
Mkt cap ! $11.70M | |||
| Open | High | Low | Value | Volume |
| 1.0¢ | 1.3¢ | 1.0¢ | $153.9K | 13.87M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 128195 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 1224999 | 4 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| CHM (ASX) Chart |